Top Menu

Bob Ehrlich

Taking on Supplements-Vascepa

It is interesting when you contrast the regulations for benefit claims for prescription drugs and OTC supplements. We all know the unproven health claims made for most supplement brands. They often have a tiny super on screen that says these claims have not been evaluated by FDA. Contrast that with prescription drugs which are regulated […]

Continue Reading 0
Bob Ehrlich

Cosentyx Lasts

It is great to have a campaign that lasts. Too many advertisers change their ad executions too quickly. Consumers benefit by seeing a good campaign kept on air. It takes a long time to establish brand recall and keeping continuity of a campaign helps with brand and ad awareness.Cosentyx, from Novartis, is one of my […]

Continue Reading 0
Bob Ehrlich

Rinvoq A New Approach

Rinvoq, a new drug for Rheumatoid Arthritis (RA), is on my creative radar this week. The AbbVie drug has an interesting 60 second spot that debuted earlier this year. There are several elements that I think are done quite well. First, the benefits are well explained with a voice over and supers for emphasis. Second, there is […]

Continue Reading 0
GumGum_PrimaryLogo-Color

How GumGum Advertising Is Helping Slow Covid-19

Ben Plomion, Chief Growth Officer Sponsored Content Though COVID-19 and its swift and pervasive impact on daily life have cast our present in a shadow of uncertainty, one thing remains clear: We’re in this together.  Overcoming the challenge to our immediate and enduring well-being is taking a combined effort––not just from hospitals, doctors, pharmaceutical companies, […]

Continue Reading 0
179706754

The Doctor Is In: Evolving Patient Care

When the world changed due to COVID-19, we adapted. With a firm digital backbone in place, as a whole we migrated to a true digital-first mindset. The coronavirus pandemic has essentially taught us how to conduct our lives online through working, educating, monitoring our health, socializing, banking, shopping, and more. We have seen the advent […]

Continue Reading 0
Social media networks tree

Back to the Future: The Post-Cookies Fate of Pharma Digital Measurement

The impending death of the third-party cookie has understandably received a lot of attention from marketers, media agencies and measurement companies – particularly in the pharma industry. Cookies – those little pieces of information left by websites and saved on browsers, allowing marketers to track online behavior and browsing history – have formed the backbone […]

Continue Reading 0
DiPersio_artwork_2-May_2020

Psychology and Technology: An Essential Mix in Digital and Social Media Pharma Marketing

Mark Zuckerberg said, “Think about what people are doing on Facebook today… they’re building an image and identity for themselves, which in a sense is their brand. They’re connecting with the audience that they want to connect to.” This is the exact strategy that pharma marketers should follow to ensure success with digital and social […]

Continue Reading 0
Phreesia_artwork

Phreesia, Harvard Team Up to Study COVID-19 Impacts

In mid-May, the Commonweath Fund, Harvard University, and Phreesia collaborated to publish findings of COVID-19 impacts on outpatient visits and telehealth; this provides an update to an earlier April publication. From mid-February to mid-May, data from more than 50,000 providers from Phreesia’s client base and more than 12 million visits was analyzed. According to the […]

Continue Reading 0
Bob Ehrlich

A Time For Hope Through Science

Dear DTC Colleague,The first campaign I have chosen to discuss is corporate. Normally I will focus on brand or disease information campaigns. In this case and at this time, however, it is highly appropriate to discuss the new Pfizer spot on research for COVID-19 which first aired April 15. The campaign is a powerful statement on what […]

Continue Reading 0